相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2
Jeffrey M. Friedman et al.
CANCER RESEARCH (2009)
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells
Antonio Strillacci et al.
EXPERIMENTAL CELL RESEARCH (2009)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2
Andrei V. Ougolkov et al.
CLINICAL CANCER RESEARCH (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Q. Cao et al.
ONCOGENE (2008)
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Sooryanarayana Varambally et al.
SCIENCE (2008)
Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis
Lingeng Lu et al.
CANCER RESEARCH (2007)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Stability and flexibility of epigenetic gene regulation in mammalian development
Wolf Reik
NATURE (2007)
MicroRNAs as cancer players: Potential clinical and biological effects
Eva Bandres et al.
DNA AND CELL BIOLOGY (2007)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Implications of micro-RNA profiling for cancer diagnosis
J. M. Cummins et al.
ONCOGENE (2006)
microRNAs exhibit high frequency genomic alterations in human cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Control of translation and mRNA degradation by miRNAs and siRNAs
MA Valencia-Sanchez et al.
GENES & DEVELOPMENT (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder
JD Raman et al.
CLINICAL CANCER RESEARCH (2005)
Combinatorial microRNA target predictions
A Krek et al.
NATURE GENETICS (2005)
Grading ovarian serous carcinoma using a two-tier system
A Malpica et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Chemotherapy for early ovarian cancer
JB Trimbos et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2004)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma
A Schmider et al.
GYNECOLOGIC ONCOLOGY (2000)
分享论文
